ライフサイエンスコーパス: tail vein injection

1 . actinomycetemcomitans were transferred via tail vein injection.

2 HBV vector were codelivered via high-volume tail vein injection.

3 essed formation of lung metastases following tail vein injection.

4 ses of more aggressive carcinoma cells after tail vein injection.

5 tively transferred to recipient mice through tail vein injection.

6 to the livers of mice by using high-pressure tail vein injection.

7 pes simplex virus type 1-specific T cells by tail vein injection.

8 , such a high expression was not found after tail vein injection.

9 ion of the liver or by systemic delivery via tail vein injection.

10 with resting Aspergillus conidia via lateral tail vein injection.

11 HepG2 colonization into lung and liver after tail vein injection.

12 and administered to healthy mice by lateral tail vein injection.

13 by administering an insulin stimulation via tail vein injection.

14 ng proved fast clearance of the tracer after tail vein injection.

15 ration of 42.1 +/- 3.9 MBq of (18)F-FMISO by tail vein injection.

16 accumulation of M2pep in TAMs in vivo after tail vein injection.

17 , or phosphate buffered saline (PBS) through tail vein injection.

18 from anesthesia when administered to mice by tail vein injection.

19 pic reinjection and of lung metastases after tail vein injection.

20 showed increased pulmonary tumor growth upon tail vein injection.

21 idiasis with C. albicans A72 administered by tail vein injection.

22 ng in vivo bioluminescence imaging following tail vein injection.

23 livers of outbred ICR mice via hydrodynamic tail vein injection.

24 in the lung after systemic administration by tail vein injection.

25 d 1 hr after initiation of sepsis via single tail-vein injection.

26 ility form lung metastases in mice following tail-vein injection.

27 le to form pulmonary tumor nodules following tail-vein injection.

28 cally investigated using intraperitoneal and tail-vein injection.

29 aluated AAV8 against AAV2 in intraportal and tail vein injections.

30 ificantly larger effects in both organs than tail vein injections.

31 ey rats (n = 36) were studied at 9.4 T after tail vein injections.

32 lung cancer cell dissemination in mice after tail vein injections.

33 hydrolase (Fah) mutant mice via hydrodynamic tail vein injections.

34 e-matched, irradiated LH(BETA)T(AG) mice via tail vein injections.

35 NS alphaS pathology in M83 mice than i.p. or tail vein injections.

36 xpressed in the mouse liver via hydrodynamic tail-vein injections.

37 yte number in living mice was assessed after tail vein injection (150 mug of each conjugate per mouse

38 Following lateral tail vein injection, 3T3 cells transformed by constituti

39 4 (Pc 4), was delivered to each animal by a tail vein injection 48 h before laser illumination.

40 he number of metastatic nodules in mice with tail vein injection and orthotopic implantation.

41 ation and inhibits metastasis to lung in the tail-vein injection and the oral cavity xenograft models

42 nomas were treated with 10 mg/kg of 5-Se via tail-vein injection and with 720 J cm(-2) of 570-750-nm

43 he vector was administered into nude mice by tail vein injection, and exogenous creatine was administ

44 ice were infected with MUP1 adenoviruses via tail vein injection, and recombinant MUP1 was overexpres

45 In the subcutaneous xenograft and tail vein injection assays, these cells had significantl

46 re retained in the murine lung 6 h following tail vein injection; coexpression of EDG2 enhanced reten

47 tumor cell extravasation into the lung after tail vein injection compared with tumors expressing wild

48 substantially inhibited lung colonization in tail vein injection experiments in immunodeficient mice.

49 In mouse tail-vein injection experiments, a construct containing

50 Following tail vein injection, fluorescence arising from dye-conju

51 ty of approximately 12 MBq (64)Cu-GPVI-Fc by tail vein injection followed by delayed (24 hours) posit

52 promoter fragments was confirmed in vivo by tail vein injection followed by luciferase reporter assa

53 pharmacokinetic data equivalent to data from tail-vein injection for small-animal (18)F-FDG PET.

54 by adeno-associated viral vector via single tail vein injection immediately following induction of M

55 ), ex vivo in murine aortas, and in vivo via tail vein injection in a 24-h murine model.

56 the blood-brain barrier, to access brain via tail vein injection in mice.

57 ting capsids by direct in vivo panning after tail vein injection in mice.

58 n immunoliposomes to the mesangium following tail vein injection in mice.

59 merulus and glomerular mesangial cells after tail vein injection in normal and nephritic mice.

60 el and that DN-PPARgamma ECV304 cells, after tail vein injection in nude mice, form lumen-obliteratin

61 imental lung metastasis model established by tail vein injection in severe combined immunodeficient m

62 and metastasis in vitro and in cells before tail vein injection in vivo.

63 nvasion and formation of lung colonies after tail-vein injection in SCID mice.

64 In addition, tail-vein injections in mice with human breast cancer MC

65 ous CIK cells were injected intravenously by tail vein injection into groups of mice, and the animals

66 )-labeled Abeta42 and Abeta40 introduced via tail vein injection into mice with a BBB rendered permea

67 Following tail vein injection into rats, (M6P)(20)-BSA-(33)P-TFO r

68 ferase-positive splenocytes, transferred via tail vein injection into the brains of HSV-infected anim

69 enhancer, was delivered through hydrodynamic tail vein injection into VWF knockout mice (VWF(-/-)) th

70 mine or polyethyleneimine alone (placebo) by tail-vein injection into nude mice with prostate and bre

71 mic administration of siMGMT-SNAs via single tail vein injection is capable of robust intratumoral MG

72 In a tail-vein injection metastatic model, Frzb-transfected H

73 in vivo BALB/c nude mice xenograft model and tail vein injection model showed that berberine treatmen

74 ased replication assay with the hydrodynamic tail vein injection model to investigate the function(s)

75 with ketamine/xylazine and catheterized for tail vein injection of (11)C-raclopride.

76 RLT was performed by administering a single tail vein injection of (177)Lu-PSMA-617 at different for

77 omized into subgroups that received either a tail vein injection of 3 x 10 orbital fat-derived stem/s

78 ution studies were done in male CD-1 mice by tail vein injection of 3.7 MBq (100 microCi) of the (11)

79 One and 2 h after tail vein injection of 30 x 10(6) ex vivo (18)F-FDG-labe

80 by counting tumor cells in lung at 6 h after tail vein injection of a mixture of fluorescently tagged

81 When SIRT4 was knocked down in vivo by tail vein injection of a shRNA adenovirus, we observed a

82 Tail vein injection of a standard Ad5-based vector into

83 rmed in an animal model of lung cancer using tail vein injection of A549 cells in SCID mice.

84 In adult mice, tail vein injection of AAV9-GFP leads to robust transduc

85 Tail vein injection of adenovirus expressing the HNF6 co

86 Finally, tail vein injection of an M2pep fusion peptide with a pr

87 A tail vein injection of anti-DLK1 Ab at 6 h after PH redu

88 PET data were acquired after tail vein injection of approximately 9 MBq of (18)F-FPAC

89 atic lung melanoma tumour-bearing mice after tail vein injection of both treatments, suggesting that

90 arrying s.c. LNCaP xenografts, a single i.v. tail vein injection of CV787 eliminates 300-mm3 tumors w

91 Tail vein injection of human endothelial specific Ulex e

92 lity of ultrafast multislice (13)C MRI after tail vein injection of hyperpolarized (13)C-phospholacta

93 Furthermore, tail vein injection of miR-223 lentiviral vector to miR-

94 to 4, microPET images were obtained after a tail vein injection of nitrogen-13 ammonia ([13N]-NH3) a

95 Following tail vein injection of OS cells into mice, both molecule

96 s of ocular and brain tissues after a single tail vein injection of SVV-001 (1 x 10(13) vp/kg) showed

97 A single tail vein injection of the rAAV8 vector was as efficient

98 njected dose per gram (%ID/g) 72 hours after tail vein injection of the radiolabeled probe in subcuta

99 the number of lung metastases 14 days after tail vein injection of tumor cells, with alveolar wall i

100 bserved in a VEGF-dependent manner following tail vein injection of tumor cells.

101 BL/6J mice were randomly assigned to receive tail vein injections of 1 mug/kg of remifentanil or norm

102 or TBI dose level per experiment were given tail vein injections of 100 microg of (131)I-labeled 30F

103 In this study, we show that mouse tail vein injections of adenovirus expressing the rat HN

104 In tail vein injections of alternative cancer models, bicar

105 Tail vein injections of Sod2-GFP-expressing HT-1080 cell

106 ter implantation only (n = 99); 176 received tail vein injections of Staphylococcus epidermidis on po

107 ost-myocardial infarction were randomized to tail-vein injection of 2x10(6) MSCs, with injection repe

108 MIR122 was inhibited in mice by tail-vein injection of an oligonucleotide antagonist of

109 Tail-vein injection of B16-F10 cells that stably express

110 tal metastasis assay we detail here includes tail-vein injection of cancer cells into the mouse and d

111 Orthotopic reinjection and tail-vein injection of cells arising from tumors, couple

112 ing, CCl4 is administered for 12 weeks after tail-vein injection of Cre-expressing adenovirus (adeno-

113 Hydrodynamic tail-vein injection of MAN2A1-FER resulted in rapid deve

114 Other groups received a tail-vein injection of serum from either HDM-sensitized

115 cell lines and for metastasis as assessed by tail-vein injection of three different tumorigenic cell

116 ice with hepatic deletion of PTEN were given tail-vein injections of MAN2A1-FER.

117 tinal (GI) tumors in immunodeficient mice by tail-vein injection rather than surgery.

118 and lung colonization after subcutaneous and tail vein injections, respectively.

119 of Cre-recombinase in ILK-floxed animals by tail vein injection resulted in acute hepatitis, with a

120 earing B16/F10 and A375M tumors at 1 h after tail vein injection revealed good B16/F10 tumor-to-backg

121 butions of the nanoparticles 24 h after i.v. tail-vein injections show that the nanoparticle accumula

122 er a functional human ABCC6 via hydrodynamic tail vein injection to approximately 13% of mouse hepato

123 ntibody (Ab; DOTA-30F11) was administered by tail vein injection to athymic mice bearing disseminated

124 CC, or control Cas9 vector, via hydrodynamic tail vein injection to livers of 8-week-old female FVB/N

125 ICAM-1 blocking antibody was administered by tail vein injection to mice following thoracic irradiati

126 toris (phLAL), purified, and administered by tail vein injections to lal( -/-) mice.

127 ioned with carbon monoxide were delivered by tail vein injections to septic mice.

128 ransposon, delivered as naked plasmid DNA by tail-vein injection, to integrate B-domain-deleted FVIII

129 was administered to Sprague-Dawley rats via tail vein injection using the carrier polyethylenimine.

130 pecific gene transfer following hydrodynamic tail vein injection using the kidney-specific podocin an

131 Metastasis to the lung via tail vein injection was reduced in the 4T1-WNT5A express

132 es for (18)F-FPA and (14)C-acetate 1 h after tail vein injection were 7.08 +/- 0.80 and 0.36 +/- 0.08

133 of these cells to form lung metastases after tail-vein injection, whereas mTerc reconstitution alone

134 BALB/c mice were infected by tail vein injection with 2 x 10(5) organisms of wild typ

135 he rAAV FIX genome in liver and spleen after tail vein injection with a higher proportion in liver af

136 nockout (CD18-ko) and wild-type (WT) mice by tail vein injection with Listeria.

137 Male BALB/c mice were infected via tail vein injection with wild-type C. albicans or with a

138 evels during BDL liver injury, we used mouse tail vein injections with recombinant adenovirus express

139 s of CN-105 (0.05 mg/kg) was administered by tail vein injection within 24 hours after ICH induction.

140 asis from orthotopic primaries and following tail vein injection without further VEGF treatment.